Michelle Guo

Michelle is an epidemiologist who advises clients on improving the traditional drug development and commercialization pipeline through the applications of machine learning, statistical modeling, and cloud-based computing. She has led R&D transformations for various life sciences companies by utilizing data-driven decision making and intelligent clinical trial design.

Prior to moving into consulting, she held roles in the biotech and pharmaceutical industries. Michelle was a R&D management consultant with a Big 4 firm where she built advanced analytics platforms for pharmaceutical and life sciences clients that drove innovation within clinical trials through reducing cost, screen failure rates, and patient burden.